Medication Prescribing

Resource Center

From the Journal

Photo Quiz

Recurrent Pruritic Erythematous and Pigmented Plaques

04/26/2024

Thomas N. Helm, MD¹ • Allison Tobias, BS² • Sarah Albert² • Robert E. Kalb, MD²

Thomas N. Helm, MD1 • Allison Tobias, BS2 • Sarah Albert 2 • Robert E. Kalb, MD2 ...

A 37-year-old woman presented to a dermatology clinic for evaluation of recurrent, pruritic, inflamed plaques on her neck, thigh, back, and shoulder. The lesions had flared at irregular sporadic intervals...

04/26/2024

Treatment

Test Your Knowledge on Diabetes: Managing Prediabetes

12/01/2010

In this “Test Your Knowledge” series, Edward Shahady, MD, asks you to choose the most appropriate treatment approach for a middle-aged Black man with prediabetes.

12/01/2010

Research Summaries

FDA ALERT

FDA Approves Nedosiran for Patients 9 Years of Age and Older With Primary Hyperoxaluria Type 1

01/29/2024

Anthony Calabro, MA

The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.

01/29/2024

Research Summary

Among Patients With Atherosclerotic Cardiovascular Disease Who Are Eligible For High-Intensity Statins, Most Are Not Using Them

01/26/2024

Jessica Ganga

Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.

01/26/2024

Conference Coverage

Palbociclib Plus Aromatase Inhibitors as First-Line Therapy For Metastatic Breast Cancer Patients With Cardiovascular Diseases

01/23/2024

Anthony Calabro, MA

Researchers conducted a retrospective analysis of 469 patients with HR+/HER2- metastatic breast cancer and cardiovascular diseases treated with palbociclib plus aromatase inhibitors or aromatase inhibitors...

01/23/2024

FDA ALERT

FDA Approves Interchangeable Biosimilar for Psoriatic Arthritis, Other Inflammatory Conditions

11/30/2023

Anthony Calabro, MA

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

11/30/2023

CONFERENCE COVERAGE

Overutilization of Potentially Inappropriate Medications Can Cause Cognitive Harm in Older Women With Breast Cancer

04/19/2023

Jessica Bard

The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...

04/19/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4